Confirmation that somatic mutations of beta-2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial

Barrow, P, Richman, SD orcid.org/0000-0003-3993-5041, Wallace, A et al. (8 more authors) (2019) Confirmation that somatic mutations of beta-2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial. Histopathology, 75 (2). pp. 236-246. ISSN 0309-0167

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 The Authors. Histopathology Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/)
Keywords: Beta2‐Microglobulin (B2M); colorectal cancer; QUASAR ; dMMR; pMMR; Mismatch‐repair
Dates:
  • Accepted: 1 May 2019
  • Published (online): 6 May 2019
  • Published: August 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Pathology & Tumour Biology (Leeds)
Funding Information:
FunderGrant number
Yorkshire Cancer ResearchL386
Depositing User: Symplectic Publications
Date Deposited: 09 May 2019 15:01
Last Modified: 13 Aug 2019 10:58
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1111/his.13895

Share / Export

Statistics